Ignite Creation Date:
2024-05-06 @ 6:39 PM
Last Modification Date:
2024-10-26 @ 2:52 PM
Study NCT ID:
NCT05735184
Status:
RECRUITING
Last Update Posted:
2024-05-16
First Post:
2023-02-09
Brief Title:
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With VenetoclaxAzacitidine Venetoclax or 73 in Patients With AML
Sponsor:
Kura Oncology Inc
Organization:
Kura Oncology Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-07-18
Start Date Type:
ACTUAL
Primary Completion Date:
2026-05
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-05
Completion Date Type:
ESTIMATED
First Submit Date:
2023-02-09
First Submit QC Date:
February 9 2023
Study First Post Date:
2023-02-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-15
Last Update Post Date:
2024-05-16
Last Update Post Date Type:
ACTUAL